XML 169 R146.htm IDEA: XBRL DOCUMENT v3.25.0.1
Earnings (Loss) Per Share (Schedule of Earnings (Loss) Per Share) (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Amounts attributable to Celanese Corporation      
Earnings (loss) from continuing operations $ (1,514) $ 1,969 $ 1,902
Earnings (loss) from discontinued operations (8) (9) (8)
Net earnings (loss) attributable to Celanese Corporation $ (1,522) $ 1,960 $ 1,894
Weighted average shares - basic (in shares) 109,273,779 108,848,962 108,380,082
Incremental shares attributable to equity awards [1] 0 530,702 855,294
Weighted average shares - diluted 109,273,779 109,379,664 109,235,376
Antidilutive securities excluded from computation of earnings per share, amount (in shares) 239,886    
Share-based Payment Arrangement, Option [Member]      
Amounts attributable to Celanese Corporation      
Antidilutive securities excluded from computation of earnings per share, amount (in shares) 265,922 202,876 0
Time Restricted Stock Units (RSUs) [Member]      
Amounts attributable to Celanese Corporation      
Antidilutive securities excluded from computation of earnings per share, amount (in shares) 61 39,465 154,172
[1] Excludes options to purchase 265,922, 202,876 and 0 shares of Common Stock for the years ended December 31, 2024, 2023 and 2022, respectively, as their effect would have been antidilutive. Excludes 61, 39,465 and 154,172 equity award shares for the years ended December 31, 2024, 2023 and 2022, respectively, as their effect would have been antidilutive. For the year ended December 31, 2024, the Company incurred a net loss from continuing operations, resulting in 239,886 incremental shares attributable to equity awards being excluded from the number of weighted average shares - diluted as their effect would have been antidilutive.